Navigation Links
Bone Densitometers Market is Expected to Reach USD 908.5 Million Globally in 2019: Transparency Market Research
Date:12/3/2013

ALBANY, New York, December 3, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Bone Densitometers Market(DEXA, QCT, pDEXA, SEXA, pQCT, RA and QUS)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global bone densitometers market was valued at USD 777.9 million in 2012 and is expected to grow at a CAGR of 3.3% from 2013 to 2019, to reach an estimated value of USD 908.5million in 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/bone-densitometers-market.html

Bone densitometry is a non-invasive diagnostic technique which involves use of bone densitometers for quantitative measurement of bone mass or density. Over a past few decades, decrease in bone mass or density has been associated with the occurrence of fractures in future and thus bone density measurement has been considered as an indicator to predict fracture risk. Moreover, people with medications for corticosteroid treatment, cancer, eating disorders, amenorrhea and genetic disorders are also preferred for evaluation of bone mineral density.

Major improvements in diagnostic technology have been witnessed since last decade due to change in perception for osteoporotic disease, growing elderly population and high expenditure to society and healthcare agencies along with the adverse effects on patients across the globe. The advances in the technology are making it possible for early detection of disease before fracture occurs. With socio-economic development in many developing countries and rapid ageing of the population, osteoporosis has become one of the most prevalent and costly health problems in these regions. Growing ageing population combined with increased vitamin D deficient patients and rise in risk for osteoporosis in pos
'/>"/>

SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
2. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
3. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
4. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
7. Ophthalmic Drugs: World Market Prospects 2012-2022
8. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
9. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
10. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ST. LOUIS, July 28, 2015  Express Scripts Holding ... net income attributable to Express Scripts stockholders of $600.1 ... diluted share, as detailed in Table 4, were $1.44 ... "It is clear many companies across healthcare are validating ... Chairman and Chief Executive Officer. "But, what matters most ...
(Date:7/28/2015)... , July 28, 2015  Nevro Corp. ... company that is providing innovative evidence-based solutions for ... publication of the SENZA-RCT results in the Online ... of the American Society of Anesthesiologists. ... study that was the first to directly compare ...
(Date:7/28/2015)... , July 28, 2015 The Physician-Patient Alliance ... safety fundraising campaign, " Surviving Your Hospital Stay ." ... care they deserve! None of these patients went home ... and Executive Director, PPAHS) referring to the patient ... National Coalition to Promote Continuous Monitoring of Patients ...
Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... Dec. 5, 2011 Tengion, Inc. (Nasdaq: TNGN ... of John L. Miclot as its President and Chief Executive ... Pincus.  He was President and Chief Executive Officer of CCS ... provider of products and services for patients with chronic diseases, ...
... 2011 The National Foundation for Infectious Diseases (NFID) ... in highlighting the importance of influenza prevention during National ... encouraging vaccination through the holiday season and beyond. ... over the past few years, but many parents remain ...
Cached Medicine Technology:Tengion Appoints John L. Miclot President and Chief Executive Officer 2Tengion Appoints John L. Miclot President and Chief Executive Officer 3Tengion Appoints John L. Miclot President and Chief Executive Officer 4National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 2National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 3National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 4
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... Wedding season is in ... wedding bells comes the extra pressure of looking good on the big day. Every bride ... pre-wedding prep to a new level. , According to a recent study ...
(Date:7/29/2015)... ... July 29, 2015 , ... CanAm Enterprises, LLC (“CanAm”) is thrilled ... past month! I-829 approvals have been granted to investors in four different CanAm EB-5 ... Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center project in CanAm’s ...
(Date:7/29/2015)... ... ... July is National UV Awareness Month, and in honor of this month, Dr. Melda Isaac ... skin from the sun, as well as how to best treat existing sun damage. Sun ... common skin conditions in America. Many people do not protect their skin sufficiently when going ...
(Date:7/29/2015)... ... 29, 2015 , ... A June 10, 2015 article from the News-Press, entitled ... importance of having regular skin cancer screenings from an early age. Skin cancer can ... When caught early, skin cancer is rarely fatal; however, if left alone for too ...
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces ... the general contact information, website, types of plans administered, years in business, and credentials ... and have at least one plan with Employee Fiduciary. A search can be done ...
Breaking Medicine News(10 mins):Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Employee Fiduciary Launches Financial Advisor Directory 2
... Feb. 28 NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ... across the United States, today announced,that Ernest G. Ludy ... the,company,s Board of Directors for personal reasons. Mr. Ludy ... intends to immediately begin a search,to identify a replacement ...
... Feb. 28 Today, Jazz,Pharmaceuticals, Inc. (Nasdaq: ... Food and Drug,Administration (FDA) has approved Once-A-Day ... treatment of social anxiety disorder,(SAD) and obsessive ... is a,selective serotonin reuptake inhibitor (SSRI) that ...
... cured 80 percent of pancreatic cancers, two-thirds of breast ... -- New research offers early evidence that hormones produced ... volume could be harnessed to treat -- and possibly ... a month of intravenous treatment with any of four ...
... Inc.,(Nasdaq: ATSI ), manufacturer and marketer of ... President and CEO of,ATS Medical, and Mike Kramer, ... to the Heart" conference at the Boston Harbor ... conference is by invitation only. The,conference will not ...
... ) today reported financial results for the fourth quarter and,twelve-month ... December 31, 2007, For the fourth quarter ended December ... $0.11 per share compared to a net loss of $23.8,million, ... The substantial,decrease in net loss is primarily due to a ...
... 2008) -- NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced today ... Holdings Inc., has made a $50 million gift to ... Hospital and Weill Cornell Medical College, in support of ... world. The gift will establish the Ronald O. Perelman ...
Cached Medicine News:Health News:NightHawk Radiology Holdings, Inc. Announces Board Member Departure 2Health News:FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD) 2Health News:FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD) 3Health News:FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD) 4Health News:FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD) 5Health News:FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD) 6Health News:Heart Hormones Beat Back Cancers in Mice 2Health News:Heart Hormones Beat Back Cancers in Mice 3Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 2Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 3Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 4Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 5Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 6Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 3Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 4Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: